Spire Healthcare has confirmed it has ended takeover talks with Bridgepoint and Triton, but discussions remain ongoing with other parties over the possible sale of the company.
Back in September, Spire revealed it was considering options including a sale. Then in December, the firm said it had commenced discussions with several parties in relation to a range of potential options.
These could include, but were not limited to, a potential sale of the business, value generation from the hospital property estate and increased strategic focus on private payors.
At the start of this year, it went further with the board issuing a statement confirming that buyout firms Bridgepoint Advisers and Triton Investment Advisers were among the parties in discussions over a possible deal to acquire the publicly listed private healthcare provider.
Spire said the talks were taking place in the context of the strategic review announced on 18 September, adding these discussions remained at a preliminary stage.
It continued that there was no certainty that any offer would be made for the company nor as to the terms of any offer, if made.
Bridgepoint and Triton had until 5pm on 21 February to announce whether or not they plan to make an offer for Spire.
Spire has now confirmed that conversations with each of Bridgepoint and Triton in relation to a possible offer for the company have terminated.
But it added that it remains in discussion with other parties in relation to a potential sale of the company.
It said there can be no certainty that any offer will be made for the company nor as to the terms of any offer, if made.
The company further confirmed its board and management is continuing to actively evaluate other appropriate actions to drive long-term, sustainable shareholder value and will make a further announcement on this matter in due course as appropriate.
Spire remains in an offer period meaning dealing disclosure requirements will continue to apply.
